XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT - 6 months ended Jun. 30, 2016 - USD ($)
$ in Thousands
Common stock
Additional paid-In capital
Series D redeemable convertible preferred stock
Additional paid-In capital
Series E redeemable convertible preferred stock
Additional paid-In capital
Accumulated deficit
Accumulated comprehensive loss
Series A redeemable convertible preferred stock
Series B redeemable convertible preferred stock
Series C redeemable convertible preferred stock
Series D redeemable convertible preferred stock
Series SRN redeemable convertible preferred stock
Series E redeemable convertible preferred stock
Total
Balance at Dec. 31, 2015             $ 3,644 $ 21,448 $ 20,178 $ 42,902 $ 12,082 $ 37,228 $ 137,482
Balance (in shares) at Dec. 31, 2015             2,589,868 7,437,325 5,000,002 8,099,994 2,111,109 8,888,888  
Increase (Decrease) in Temporary Equity [Roll Forward]                          
Accretion of preferred stock to redemption value             $ 75 $ 449 $ 446 $ 1,131 $ 913 $ 1,552 4,566
Conversion of convertible stock upon listing             $ (3,719) $ (21,897) $ (20,624) $ (44,033) $ (12,995) $ (38,780)  
Conversion of convertible stock upon listing (in shares)             (2,589,868) (7,437,325) (5,000,002) (8,099,994) (2,111,109) (8,888,888)  
Balance at Jun. 30, 2016                     $ 5,000    
Balance (in shares) at Jun. 30, 2016             0 0 0 0 0 0  
Balance at Dec. 31, 2015       $ 1 $ (111,508) $ (4,986)             (116,493)
Balance (in shares) at Dec. 31, 2015 2,173,399                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Vesting of restricted common stock       10                 10
Vesting of restricted common stock (in shares) 3,791                        
Issuance of common stock upon exercise of options       48                 48
Issuance of common stock upon exercise of options (in shares) 25,210                        
Exercise of common warrants (in shares) 567,306                        
Stock based compensation expense       649                 649
Accretion of preferred stock to redemption value       (708) (3,858)               (4,566)
Conversion of convertible stock upon listing $ 1     142,047                 142,048
Conversion of convertible securities upon listing (in shares) 10,126,118                        
Issuance of common stock, initial public offering net of issuance costs of $9,224 $ 5,000,000     60,776                 60,776
Conversion of preferred stock warrants into warrants for the purchase of common stock   $ 189 $ 113             $ 189   $ 113  
Currency translation adjustment           401             401
Net loss         (14,399)               (14,399)
Balance at Jun. 30, 2016 $ 1     $ 203,125 $ (129,765) $ (4,585)             $ 68,776
Balance (in shares) at Jun. 30, 2016 17,895,824